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Abstract In this study, bioactive glass (BG, 45S5) par-
ticles were added to a biodegradable magnesium alloy
(ZK30) through a semi-solid high-pressure casting process
in order to improve the surface biocompatibility of the
biomaterial and potentially its bioactivity. The observation
of the as-cast microstructures of ZK30-BG composites
indicated homogeneous dispersion of BG particles in the
matrix. SEM, EDX and EPMA showed the retention of the
morphological characteristics and composition of BG par-
ticles in the as-cast composite materials. In vitro tests in a
cell culture medium conﬁrmed that the composites indeed
possessed an enhanced ability to induce the deposition of a
bone-like apatite layer on the surface, indicating an
improved surface biocompatibility as compared with the
matrix alloy.
1 Introduction
In recent years, magnesium alloys have attracted much
attention as potential biodegradable bone implant materials
due to their biodegradability in the bioenvironment as well
as their favourable mechanical properties, especially the
elastic modulus being close to that of the bone which will
effectively decrease the stress shielding effect [1, 2]. Many
studies have been conducted on magnesium and its alloys
for orthopaedic implants. Most of these studies are focused
on the ways to improve corrosion resistance in physiolog-
ical media, for example, through alloying [3] or coating [4].
Quite encouraging results have been obtained. Further in
vitro and in vivo tests will provide essential data for further
material and process optimization before the pre-clinical
test stage is reached.
Another issue of these potential biomedical materials,
being as important as corrosion resistance but not always
addressed, concerns their bioactivity, i.e. the ability of the
implant to form bonding with the surrounding bone tissue
after implantation. While a number of in vivo studies have
shown good bone attachment to magnesium implants after
9 to 18 week implantation and good biocompatibility of
magnesium in long-term service [5, 6], some other research
on the early bone response to magnesium bone implants
has led to inconsistent results. For example, only 50% of
magnesium implants were ﬁxed at 5 weeks post-implanta-
tion [7]. In some cases, gaps could still be observed between
the implant and bone tissue after 14-week implantation [6],
even though the material showed a moderate degradation
rate. It is clear that efforts are needed to improve the surface
biocompatibility and bioactivity of Mg-based materials and
speed up the early tissue response to the implant [8].
Introducing bioactive particles that have good ability to
induce the deposition of Ca–P compounds from simulated
body ﬂuid into a metal matrix to form a metal matrix
composite may be an effective way to elevate the surface
biocompatibility and bioactivity of the matrix material, as
demonstrated in a recent study [9]. Ning and Zhou [10]
reported that a Ti/hydroxyapatite (HA) biocomposite (with
a Ti/HA ratio of 1:1 by volume) indeed had the ability to
induce apatite nucleation and growth on its surface in
simulated body ﬂuid. Witte et al. [11] designed a composite
with AZ91D as the matrix and HA particles as reinforce-
ment. Their results showed that the composite with 20%
HA by weight was a cytocompatible biomaterial and the
distribution and size of HA particles were of major
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however known that HA has a minimal degradability and
its bioactivity still needs to be improved [12].
A previous study demonstrated a moderate degradation
rate and good cytocompatibility of ZK30 (3 wt% Zn, 0.6
wt% Zr and balance Mg) [13] that contained no potentially
toxic elements such as aluminium in AZ91. The present
study was aimed at exploring the feasibility of using
commonly acknowledged bioactive and biodegradable
glass (BG, 45S5) as the reinforcing phase in the composites
with the ZK30 magnesium alloy as the matrix and con-
ﬁrming the surface biocompatibility of the composites. The
structures of the composites, including the distribution of
bioactive particles in the matrix as well as their mechanical
properties were investigated. The surface biocompatibility
of the composites was evaluated by characterizing the
corrosion layer on samples soaked in a cell culture medium
and comparing it with that of the matrix sample.
2 Experimental
2.1 Material preparation
ZK30-BG composites were prepared by a semi-solid, high
pressure casting method. The ZK30 alloy was heated to
635C to reach a semi-solid state. 45S5 bioglass particles
with a composition of 45% SiO2, 24.5% Na2O, 24.5% CaO
and 6% P2O5 by weight were introduced. Upon stirring, the
mixture was cast into a cylindrical form by using a high
pressure casting machine. The bioglass powder had a
median size of 40 lm. The volume fractions of BG parti-
cles in the composites were 3.4, 6.9 and 14.3%, corre-
sponding to 5, 10 and 20% by weight, respectively.
2.2 Observation of microstructure and determination
of mechanical properties
Samples for microstructure observation were cut from the
ingots, ground by SiC papers up to 2000 grit, and then
polished down to 1 lm. A Leica optical microscope and a
scanning electron microscope (SEM, JSM-6500F, JEOL)
combined with an energy dispersive X-ray (EDX) spec-
trometer (INCA Energy, Oxford Instruments) were used.
Furthermore, a JEOL JXA 8900R electron probe micro-
analyzer (EPMA) was used to determine the distribution of
the silicon element in the composites. The acceleration
voltage was set at 15 keV and the probe current at 100 nA
using a focused electron beam. The size of the analysis area
was 100 9 100 lm
2 with a step size of 1.0 lm.
For compressive testing, specimens with a length of
15 mm and a diameter of 10 mm were machined in
accordance with DIN EN 50106. Tests were performed at a
crosshead speed of 1 mm/min. Three repeat tests were
performed for each material.
2.3 Immersion test
The immersion test was conducted by soaking samples in
the cell culture medium (minimum essential medium with
Earle’s balanced salts, SAFC Bioscience Inc., USA). The
minimum essential medium with Earle’s balanced salts
(E-MEM) was selected, because it represents the ion con-
centrations of blood plasma and contains some kinds of
amino acid that is also present in human plasma [14]. The
concentrations of ions in E-MEM in comparison with those
in the human blood are listed in Table 1. The as-fabricated
composites as well as the ZK30 alloy were cut into disks
with a diameter of 10 mm and a thickness of 2 mm. The
surfaces of the samples were ground by SiC papers up to
2000 grit, polished down to 1 lm and dried, before they
soaked in E-MEM. A disk was immersed in the E-MEM
solution with a volume of 22 ml at 37.0C, thus the ratio of
the volume of the solution to the apparent surface area of
the disk being 0.1 cm
-1 [15].
After soaking in the cell culture medium for 24 h, the
samples were taken out and dried. Structural changes were
examined using SEM combined with EDX.
3 Results and discussion
Figure 1 shows the microstructures of the ZK30-BG
composites with different volume fractions of BG particles.
As can be seen, black particles are homogeneously dis-
persed in the matrix and the number density of the black
particles indeed increases with increasing volume fraction
of BG particles as desired (Fig. 1a, c, e). SEM revealed that
Table 1 Ion concentrations in human blood and E-MEM [13]
Na
?
(mmol/l)
K
?
(mmol/l)
Ca
2?
(mmol/l)
Mg
2?
(mmol/l)
C
1-
(mmol/l)
HCO3
-
(mmol/l)
HPO4
2-
(mmol/l)
SO4
2-
(mmol/l)
Amino acids
(mg/l)
Dex/Glu
(g/l)
Blood plasma 142 5.0 2.5 1.5 103 27 1.0 0.5 ND ND
E-MEM 151 5.37 1.80 0.811 125 26.2 0.897 0.811 0.0860 1
ND not determined
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initial BG powder particles, suggesting little reaction took
place during material preparation. In addition, SEM
showed some more details of the microstructures of the
composites. The composites with 3.4 and 6.9% BG by
volume were slightly porous and most of the pores had
sizes below 10 lm (Fig. 1b, d). The difference in porosity
between these two composites was not distinct. However,
in the composite with 14.3% BG particles by volume, the
pore sizes were considerably larger (Fig. 1f). In a com-
posite ingot made by the semi-solid casting method, in
general, porosity may arise from (i) gas entrapment during
mixing, (ii) hydrogen evolution, and (iii) shrinkage during
solidiﬁcation [16]. For the present composites, the porosity
might result from gas bubbles entering the slurry either
independently or as gas envelopes of the reinforcing par-
ticles. Indeed, it was observed that the porosity in stir-cast
composites increased almost linearly with particle content
[16]. Such an increase in porosity will have an adverse
effect on the mechanical strength of the composite. As
shown in Fig. 2, the compressive strength of the composite
indeed decreased from 330 to 240 MPa as the volume
fraction of BG particles increased from 0 to 14.3%. It is
however important to note that the strengths of the com-
posites are still considerably higher than the typical
strength of human cortical bone (88.3–163.8 MPa) [17]
and therefore the sacriﬁce in strength due to the BG par-
ticles and associated porosity is not a matter of serious
concern. The effect of the porosity may be more on the
degradation rate than on the compressive strength and,
Fig. 1 Surface morphologies of the ZK30-BG composites with 3.4%
(a, b), 6.9% (c, d) and 14.3% (e, f) BG particles by volume under
optical microscope (a, c, e) and SEM (b, d, f). The black arrows point
at the reinforcing particles, while the white ones point at the pores in
the composites
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residual pores in the structure. Vacuum hot pressing, hot
isostatic pressing and especially hot extrusion involving
strong shearing have been proven to be effective methods
capable of consolidating initially porous materials.
Since the biomedical property of a bioactive ceramic
material is closely related to its chemical composition, it is
of utmost importance to keep the compositional charac-
teristics of BG particles in the composite unchanged [18].
In general, it is rather difﬁcult to ascertain the retention of
the chemical composition of BG particles due to their
amorphous structure. In the present study, EDX analysis
was performed to conﬁrm the compositional retention of
BG particles in the composites. As can be seen from
Fig. 3a, only Mg, Zn and a small amount of element O
were detected by EDX, and the mass ratio of Mg and Zn
was close to that of the designed ZK30 composition, which
means that the matrix composition was well preserved after
the casting procedure. As to the BG particles in the com-
posites, EDX analysis revealed the presence of Ca, Si, Na,
O and a small amount of Mg (Fig. 3b). The presence of Mg
could be attributed to the magnesium surrounding the BG
particles or to mild reactions at the interfaces between the
matrix and BG particles. For a clearer comparison, the
weight percents of Ca, Si, Na and O of the analyzed par-
ticles as determined by EDX are listed in Table 2 and
compared with those of the theoretical elemental compo-
sition of BG particles. It can be seen that the discrepancies
between the as-measured and theoretical composition data
were not marked, suggesting the retention of BG particles
in the composites. It is of particular importance to note the
high Si concentration in the BG particles, which is neces-
sary for the excellent bioactivity of a bioactive glass [18].
EPMA analysis indeed revealed the silicon element with
enhanced intensities scattered all over the matrix, which
corresponded to the locations of BG particles (Fig. 4). It
was thus clear that the basic chemical composition of BG
particles remained largely intact during semi-solid high
pressure casting, which would be essential for the preser-
vation of their bioactivity. In other words, semi-solid high
pressure casting appeared to be a viable method to fabricate
ZK30-BG composites.
Fig. 2 Compressive strengths of the ZK30-BG composites with
different volume fractions of BG particles
Fig. 3 EDX analysis of the
matrix (a) and particles
(b) in the ZK30-BG composites
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123The surface morphologies of the composites after
immersion in E-MEM for 24 h are shown in Fig. 5. During
immersion, pitting corrosion indeed occurred on the sur-
face of the ZK30 alloy sample without BG reinforcement
(Fig. 5a). In contrast, a deposition layer was formed on the
surface of the composite samples, and the area of this layer
increased with increasing volume fraction of BG particles
in the composite (Fig. 5b, d). EDX analysis of the surface
layer showed increases in the Ca atomic percent and Ca/P
molar ratio, as the volume fraction of BG particles
increased from 0 to 14.3% (Fig. 6). The Ca/P ratios of the
composites in the range of 1.2–1.35, being lower than the
theoretical value (1.67), show that the newly formed apatite
layer is a Ca-deﬁcient apatite layer, consistent with the
properties of bone-like apatite formed on an HA-bioglass
composite [19] and on bioglass [20]. The results indicated
that the BG particles present in the composite were indeed
able to induce faster and more homogeneous deposition of
a Ca- and P-rich layer on the magnesium alloy matrix. The
operating mechanism of spontaneous apatite formation on
metallic magnesium may be as follows [21]: an ionic
exchange between Mg
2? from the substrate and H
? from
the soaking medium takes place, leading to an increase in
pH; higher pH values increase the supersaturation degree
Table 2 EDX determined composition of BG particles in the com-
posites in comparison with the designed composition of BG (wt %)
Ca Si Na O Mg
As-designed 17.5 21.0 18.2 40.7 0
As-measured 22.3 29.7 14.2 30.6 3.2
Fig. 4 Distribution of Si in the composite as determined by EPMA.
The analysis area on a ZK30-BG MMC sample is indicated by the
square in the Backscattered Electron Image (BEI). The intensity of
the Si Ka in the framed area is represented by the gray scale (or a jet-
like colour scheme in the online version). Here black represents a low
signal and light gray-white higher intensity signals (pinkish-white the
highest intensity in the online version)
Fig. 5 SEM micrographs of the ZK30 alloy (a) and the composites
with 3.4% (b), 6.9% (c) and 14.3% (d) BG particles by volume after
immersion in E-MEM for 24 h
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result is the nucleation and growth of a Ca-, P- and Mg-rich
ceramic layer on the magnesium substrate. With the addi-
tion of BG particles, apart from the supersaturation caused
by the elevated pH environment, the apatite layer forma-
tion is accelerated due to the release of Ca
2? from the
partial dissolution of BG particles. The silicon dissolved
from the BG particles surface may act as a nucleating agent
[18], thereby accelerating the formation of the apatite layer
which can signiﬁcantly improve the surface biocompati-
bility of the material [8, 9]. In combination with the con-
sideration on the compressive strengths of the composites
(Fig. 2), the ZK30-BG composite with 6.9% BG by vol-
ume showed the best balanced properties. Further research
on the biocompatibility and bioactivity of the composites
and other aspects relevant to the biomedical application
will be carried out to optimize both material design and
processing further.
4 Conclusions
For the ﬁrst time, Mg-based metal matrix composites with
bioactive glass as reinforcing particles were fabricated by
the semi-solid high pressure casting method. BG particles
were homogeneously distributed in the composites. The
materials showed slightly porous structures and had com-
promised mechanical strengths. Nevertheless, BG particles
survived the casting process with their chemical composi-
tion intact. Accelerated formation of an apatite layer on the
composite surface occurred, indicating an improved sur-
face biocompatibility of the material. These results dem-
onstrated the feasibility of improving the surface
biocompatibility of Mg-based implant materials by adding
bioactive particles. Further research on material-cell
interactions would be of great value to show the potential
of the composites as biodegradable, bioactive orthopaedic
materials.
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